Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

OMICRON (B.1.1.529): A new SARS‐CoV‐2 variant of concern mounting worldwide fear
Vikram Thakur, Radha Kanta Ratho
Journal of Medical Virology (2021) Vol. 94, Iss. 5, pp. 1821-1824
Open Access | Times Cited: 242

Showing 1-25 of 242 citing articles:

Emergence of SARS-CoV-2 Omicron (B.1.1.529) variant, salient features, high global health concerns and strategies to counter it amid ongoing COVID-19 pandemic
Rekha Khandia, Shailja Singhal, Taha Alqahtani, et al.
Environmental Research (2022) Vol. 209, pp. 112816-112816
Open Access | Times Cited: 273
Molecular characteristics, immune evasion, and impact of SARS-CoV-2 variants
Cong Sun, Chu Xie, Guo‐Long Bu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 113
SARS‐CoV‐2 Omicron variant: Immune escape and vaccine development
Danyi Ao, Tianxia Lan, Xuemei He, et al.
MedComm (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 105
Proportion of asymptomatic infection and nonsevere disease caused by SARS‐CoV‐2 Omicron variant: A systematic review and analysis
Weien Yu, Yifei Guo, Shenyan Zhang, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 12, pp. 5790-5801
Open Access | Times Cited: 88
Advances in the development of therapeutic strategies against COVID-19 and perspectives in the drug design for emerging SARS-CoV-2 variants
Jialing Yin, Chengcheng Li, Chunhong Ye, et al.
Computational and Structural Biotechnology Journal (2022) Vol. 20, pp. 824-837
Open Access | Times Cited: 64
Omicron variant (B.1.1.529) of SARS-CoV-2: understanding mutations in the genome, S-glycoprotein, and antibody-binding regions
Manojit Bhattacharya, Ashish Ranjan Sharma, Kuldeep Dhama, et al.
GeroScience (2022) Vol. 44, Iss. 2, pp. 619-637
Open Access | Times Cited: 56
The Omicron subvariant BA.2: Birth of a new challenge during the COVID-19 pandemic
Farid Rahimi, Amin Talebi Bezmin Abadi
International Journal of Surgery (2022) Vol. 99, pp. 106261-106261
Open Access | Times Cited: 51
The SARS‐CoV‐2 Omicron (B.1.1.529) variant and effectiveness of existing vaccines: What we know so far
Md. Sohan, Md. Jamal Hossain, Md. Rabiul Islam
Journal of Medical Virology (2022) Vol. 94, Iss. 5, pp. 1796-1798
Open Access | Times Cited: 43
Is Omicron the end of pandemic or start of a new innings?
Swarnali Das, Sovan Samanta, Jhimli Banerjee, et al.
Travel Medicine and Infectious Disease (2022) Vol. 48, pp. 102332-102332
Open Access | Times Cited: 43
The Vaccine Efficacy Against the SARS-CoV-2 Omicron: A Systemic Review and Meta-Analysis
Yuntao Zou, Doudou Huang, Qian Jiang, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 41
The Emergence of the Omicron (B.1.1.529) SARS-CoV-2 Variant: What is the Impact on the Continued Pandemic?
Jaffar A. Al‐Tawfiq, Van Thuan Hoang, Nhat Le Bui, et al.
Journal of Epidemiology and Global Health (2022) Vol. 12, Iss. 2, pp. 143-146
Open Access | Times Cited: 37
Diagnostics and analysis of SARS-CoV-2: current status, recent advances, challenges and perspectives
Tao Dong, Mingyang Wang, Junchong Liu, et al.
Chemical Science (2023) Vol. 14, Iss. 23, pp. 6149-6206
Open Access | Times Cited: 35
Omicron Variant of SARS-CoV-2: An Indian Perspective of Vaccination and Management
Vivek P. Chavda, Pankti C. Balar, Dixa A. Vaghela, et al.
Vaccines (2023) Vol. 11, Iss. 1, pp. 160-160
Open Access | Times Cited: 28
Reversal of the unique Q493R mutation increases the affinity of Omicron S1-RBD for ACE2
Angelin M. Philip, Wesam S. Ahmed, Kabir H. Biswas
Computational and Structural Biotechnology Journal (2023) Vol. 21, pp. 1966-1977
Open Access | Times Cited: 26
SARS-CoV-2 Omicron (B.1.1.529) Variant: A Challenge with COVID-19
Zeinab Mohseni Afshar, Ali Tavakoli Pirzaman, Bardia Karim, et al.
Diagnostics (2023) Vol. 13, Iss. 3, pp. 559-559
Open Access | Times Cited: 23
Increased public health threat of avian-origin H3N2 influenza virus caused by its evolution in dogs
Mingyue Chen, Yanli Lyu, Fan Wu, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 21
Potential immune evasion of the severe acute respiratory syndrome coronavirus 2 Omicron variants
Luyi Chen, Ying He, Hongye Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 8
CRISPR‐Cas system: A promising tool for rapid detection of SARS‐CoV‐2 variants
Jing Li, Kuo Zhang, Guigao Lin, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 1
Closed Access | Times Cited: 7
The Omicron variant of concern: The genomics, diagnostics, and clinical characteristics in children
Djatnika Setiabudi, Yunia Sribudiani, Kartika Hermawan, et al.
Frontiers in Pediatrics (2022) Vol. 10
Open Access | Times Cited: 33
Emergence of SARS-CoV-2 New Variants and Their Clinical Significance
Hitesh Singh, Nisha Dahiya, Mahima Yadav, et al.
Canadian Journal of Infectious Diseases and Medical Microbiology (2022) Vol. 2022, pp. 1-8
Open Access | Times Cited: 32
Aprotinin treatment against SARS‐CoV‐2: A randomized phase III study to evaluate the safety and efficacy of a pan‐protease inhibitor for moderate COVID‐19
Francisco Javier Redondo Calvo, Juan Fernando Padín, José Ramón Muñoz‐Rodríguez, et al.
European Journal of Clinical Investigation (2022) Vol. 52, Iss. 6
Open Access | Times Cited: 29
The Omicron (B.1.1.529) SARS-CoV-2 variant of concern also affects companion animals
Lidia Sánchez‐Morales, José Manuel Sánchez‐Vizcaíno, Marta Pérez‐Sancho, et al.
Frontiers in Veterinary Science (2022) Vol. 9
Open Access | Times Cited: 29
A perspective on SARS-CoV-2 virus-like particles vaccines
Gao Xiaoyang, Yeting Xia, Xiaofang Liu, et al.
International Immunopharmacology (2023) Vol. 115, pp. 109650-109650
Open Access | Times Cited: 17
Mediating effect of resilience and fear of COVID-19 on the relationship between social support and post-traumatic stress disorder among campus-quarantined nursing students: a cross-sectional study
Dongmei Zhang, Qin Li, Anle Huang, et al.
BMC Nursing (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 17
Omicron (B.1.1.529) variant and its subvariants and lineages may lead to another COVID-19 wave in the world? -An overview of current evidence and counteracting strategies
Ranjit Sah, Mohammed Amir Rais, Aroop Mohanty, et al.
International Journal of Surgery Open (2023) Vol. 55, pp. 100625-100625
Open Access | Times Cited: 17
Page 1 - Next Page

Scroll to top